Low-dose ofatumumab for multidrug-resistant nephrotic syndrome in children: a randomized placebo-controlled trial.
Pietro RavaniIsabella PisaniMonica BodriaGianluca CaridiMaria Ludovica Degl'InnocentiGian Marco GhiggeriPublished in: Pediatric nephrology (Berlin, Germany) (2020)
https://clinicaltrials.gov: NCT02394106.